APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 56 filers reported holding APTEVO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $51,000 | +45.7% | 78,456 | +32.0% | 0.00% | – |
Q3 2019 | $35,000 | -34.0% | 59,439 | 0.0% | 0.00% | – |
Q2 2019 | $53,000 | -1.9% | 59,439 | -1.4% | 0.00% | – |
Q1 2019 | $54,000 | -37.9% | 60,259 | -12.2% | 0.00% | – |
Q4 2018 | $87,000 | -75.6% | 68,600 | -2.0% | 0.00% | – |
Q3 2018 | $356,000 | +1.1% | 70,003 | -0.6% | 0.00% | – |
Q2 2018 | $352,000 | +85.3% | 70,416 | +21.2% | 0.00% | – |
Q1 2018 | $190,000 | -19.1% | 58,117 | +4.9% | 0.00% | – |
Q4 2017 | $235,000 | +95.8% | 55,399 | +5.6% | 0.00% | – |
Q3 2017 | $120,000 | +10.1% | 52,460 | -0.6% | 0.00% | – |
Q2 2017 | $109,000 | -73.3% | 52,774 | -73.4% | 0.00% | – |
Q1 2017 | $408,000 | -20.5% | 198,268 | -5.7% | 0.00% | – |
Q4 2016 | $513,000 | -13.5% | 210,178 | -9.3% | 0.00% | – |
Q3 2016 | $593,000 | – | 231,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,413,421 | $2,008,000 | 1.95% |
Worth Venture Partners, LLC | 375,669 | $221,000 | 0.13% |
Park West Asset Management LLC | 1,000,000 | $588,000 | 0.03% |
ALGERT GLOBAL LLC | 74,906 | $44,000 | 0.02% |
Sessa Capital IM, L.P. | 180,149 | $106,000 | 0.01% |
ATLAS CAPITAL ADVISORS LLC | 49,045 | $28,858,000 | 0.01% |
Point72 Asset Management, L.P. | 2,450,000 | $1,442,000 | 0.01% |
Alyeska Investment Group, L.P. | 750,000 | $441,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 78,000 | $46,000 | 0.00% |
A.R.T. Advisors, LLC | 69,934 | $41,000 | 0.00% |